News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor

Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Wisconsin facility will be capable of producing one-third of global demand molybdenum-99 radioisotope

Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.

The groundbreaking follows the recent transfer of 91 acres of land from the City of Janesville located across from the Southern Wisconsin Regional Airport. Once complete, the 43,000-square-foot facility will be home to eight of Shine’s accelerator-based medical isotope production systems, capable of producing more than one-third of global demand for the medical isotope molybdenum-99 (Mo-99). Shine currently employs more than 90 people and expects to hire approximately 60 more before the completion of the facility.

“I am very proud of the role NNSA has played in our public-private partnership with SHINE,” Gordon-Hagerty said. “Not only are we assisting in saving lives, but we are promoting the elimination of material in civilian applications that might otherwise fall into an adversary’s hands for use in a terrorist threat. DOE/NNSA looks forward to celebrating future successes together.”

Domestic production of molybdenum has been an important topic for many years. Molybdenum-99 (Mo-99) is the precursor element to technetium-99m (Tc-99m), the most widely used radioisotope in medical imaging. Prior to 2018, Mo-99 could only be produced from enriched uranium by facilities outside the United States. This required a complicated supply chain that involved shipping enriched uranium from the U.S. According to the U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC), this left the U.S. vulnerable to possible shortages and/or supply chain issues. The situation became more urgent in 2016 when Chalk River Laboratories (CRL), the Canadian facility that was the world’s largest production reactor for medical nuclear imaging isotopes, ceased production of Mo-99.

Last year, the FDA cleared the way for the first domestic supply of Tc-99m with the approval of the NorthStar Medical Radioisotopes’ RadioGenix System, which produces Mo-99.

For more information: www.shinemed.com

Related Mo-99 Content

FDA Clears Path for First Domestic Supply of Tc-99m Isotope

Chalk River Isotope Reactor Decommissioning Date Set

Related Content

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
A 3-D printed tungsten X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | April 29, 2019 | By Steve Jeffery
In ...
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...